Source: Beidaihe New District
On June 17, Beidaihe New District signed a strategic cooperation agreement with Japan Research Institute of Symbiosis Medicine, which is engaged in high-end medical technology research and development, with 11 high-end medical technology projects represented by immune cell (BAK) therapy. It is a professional company consisting of medical care, chronic disease management and tourism, which cultivates technical talents for professional institutions of cell culture.
In accordance with the agreement signed by the two sides, the institution will cooperate in the field of cancer prevention and treatment in Beidaihe New District, to create a benchmark demonstration medical institution for the world’s top cancer treatment specialist hospitals, professional training colleges, cell culture factories and health care centers. With a total investment of about 3 billion yuan, it is the first project invested by the Japan Research Institute of Symbiosis Medicine outside Japan.
International Channel
http://www.qhdnews.com/en/index/
International Channel Mobile Client
http://www.qhdnews.com/en/mobile
Chinese manuscript